OrSense has reported that hemoglobin (Hb) measurements obtained by its NBM 200 showed accurate performance compared with invasive point of care (POC) devices.

OrSense has presented the NBM 200 results at the AABB Annual Meeting & CTTXPO 2010, in Baltimore, Maryland.

NBM 200 is a non-invasive Hb measurement system used for anemia screening and hemorrhage and offers a non-invasive solution for accurate and quick Hb measurements, OrSense said.

NBM 200 operates via a ring-shaped sensor that is fitted on the donor’s finger and applies pressure, temporarily occluding local blood flow.

International Society of Blood Transfusion former president Paul Holland said that OrSense’s non-invasive solution has the potential for improving anemia screening and monitoring by eliminating pain, reducing infection risk and enabling a simple and fast diagnosis.

OrSense is a medical device company developing non-invasive monitoring systems for measurements of oxygen saturation, hemoglobin, glucose and other blood parameters.